We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$121B
AUM Growth
+$6.29B
Cap. Flow
+$257M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.67%
Holding
4,045
New
183
Increased
1,650
Reduced
1,805
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 15.49%
2 Financials 8.61%
3 Healthcare 8.48%
4 Industrials 6.86%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTXL icon
1026
First Trust Nasdaq Semiconductor ETF
FTXL
$1.33B
$10.5M 0.01%
147,509
+63,894
+76% +$4.09M
MTCH icon
1027
Match Group
MTCH
$8.45B
$10.5M 0.01%
250,635
-1,210
-0.5% -$44.2K
ATSG
1028
DELISTED
Air Transport Services Group
ATSG
$10.5M 0.01%
555,243
-270,755
-33% -$5.04M
VTHR icon
1029
Vanguard Russell 3000 ETF
VTHR
$4.84B
$10.5M 0.01%
52,971
+12,482
+31% +$2.34M
LW icon
1030
Lamb Weston
LW
$7.23B
$10.4M 0.01%
90,717
+3,026
+3% +$338K
RCKY icon
1031
Rocky Brands
RCKY
$355M
$10.4M 0.01%
494,971
-100,312
-17% -$2.2M
RLI icon
1032
RLI Corp
RLI
$5.87B
$10.4M 0.01%
152,100
-354
-0.2% -$23.5K
PINS icon
1033
Pinterest
PINS
$13.4B
$10.4M 0.01%
378,789
+251,404
+197% +$6.27M
AGO icon
1034
Assured Guaranty
AGO
$3.31B
$10.3M 0.01%
185,421
+18,016
+11% +$958K
LVS icon
1035
Las Vegas Sands
LVS
$29.6B
$10.3M 0.01%
178,013
+3,708
+2% +$219K
HEI icon
1036
HEICO Corp
HEI
$51.3B
$10.3M 0.01%
58,017
+4,079
+8% +$688K
RGLD icon
1037
Royal Gold
RGLD
$19.8B
$10.2M 0.01%
89,288
-2,889
-3% -$372K
IHE icon
1038
iShares US Pharmaceuticals ETF
IHE
$1.65B
$10.2M 0.01%
171,552
-19,752
-10% -$1.17M
DGX icon
1039
Quest Diagnostics
DGX
$26.2B
$10.2M 0.01%
72,754
-967
-1% -$133K
OMCL icon
1040
Omnicell
OMCL
$1.68B
$10.2M 0.01%
138,662
+5,170
+4% +$349K
SBSW icon
1041
Sibanye-Stillwater
SBSW
$7.51B
$10.2M 0.01%
1,628,251
+282,637
+21% +$2.23M
WPP icon
1042
WPP
WPP
$5.83B
$10.1M 0.01%
194,053
-942
-0.5% -$53K
ITB icon
1043
iShares US Home Construction ETF
ITB
$2.4B
$10.1M 0.01%
118,059
+30,403
+35% +$2.31M
LFUS icon
1044
Littelfuse
LFUS
$11.5B
$10.1M 0.01%
34,552
-3,943
-10% -$1.03M
RBA icon
1045
RB Global
RBA
$16.6B
$10.1M 0.01%
167,745
+1,159
+0.7% +$65.3K
ZG icon
1046
Zillow
ZG
$7.71B
$10M 0.01%
204,204
-1,127
-0.5% -$50.8K
OBDC icon
1047
Blue Owl Capital
OBDC
$5.76B
$10M 0.01%
747,860
+148,734
+25% +$1.94M
RHI icon
1048
Robert Half
RHI
$4.31B
$10M 0.01%
133,266
+16,611
+14% +$1.19M
OSK icon
1049
Oshkosh
OSK
$9.62B
$10M 0.01%
115,715
+78,174
+208% +$6.16M
DKNG icon
1050
DraftKings
DKNG
$12.6B
$10M 0.01%
377,011
+31,660
+9% +$730K

Similar funds

Raymond James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Raymond James & Associates held 4,045 positions worth $121B, up 5.5% from $115B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q2 2023 filing shows 183 new, 1,650 increased, 1,805 reduced and 213 closed positions. Its largest new stake was Choice Hotels: 212,259 shares worth $24.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $562M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2023 buy was Choice Hotels: 212,259 shares worth $24.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2023, an estimated $753M increase.
  • Raymond James & Associates's biggest Q2 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $562M.
  • Raymond James & Associates fully exited ABB Ltd in Q2 2023, selling an estimated $17.1M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $121B portfolio in Q2 2023.
  • Raymond James & Associates opened 183 new positions and closed 213 in Q2 2023.
  • Raymond James & Associates's portfolio value rose 5.5% quarter-over-quarter to $121B.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.